financetom
Business
financetom
/
Business
/
Merck's cholesterol drug meets main goal in late-stage trial
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Merck's cholesterol drug meets main goal in late-stage trial
Sep 2, 2025 4:18 AM

Sept 2 (Reuters) - Drugmaker Merck said on

Tuesday its oral drug met the main goal of reducing bad

cholesterol in patients in a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved